[1] J. Hardy, D. J. Selkoe, “The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics” Science 297 (5580): 353-356, 2002.
[2] S. Musardo, C. Saraceno, S. Pelucchi, E. Marcello, “Trafficking in neurons: Searching for new targets for Alzheimer's disease future therapies” European Journal of Pharmacology 719 (1–3): 84-106, 2013.
[3] C. R. Harrington, "The Molecular Pathology of Alzheimer's Disease" Neuroimaging Clinics of North America. 22 (1): 11-22, 2012.
[4] W. M. Tay, D. Huang, T. L. Rosenberry, A. K. Paravastu, "The Alzheimer's Amyloid-β(1–42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization" Journal of Molecular Biology 425 (14): 2494-2508, 2013.
[5] K. L. Sciarretta, D. J. Gordon, S. C. Meredith, "Peptide‐Based Inhibitors of Amyloid Assembly, in Methods in Enzymology" K. Indu and W. Ronald, Editors, Academic Press: 273-312, 2006.
[7] L. O. Tjernberg, et al. "Arrest of beta-amyloid fibril formation by a pentapeptide ligand" J Biol Chem 271 (15): 8545-8, 1996.
[8] C. Soto, "Alzheimer’s and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches" Journal of Molecular Medicine 77 (5): 412-418, 1999.
[9] C. Soto, et al. "Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation" Biochem Biophys Res Commun 226 (3): 672-80, 1996.
[10] C. Peters, M. S.
Kindy, M.
Baumann, B.
Frangione, "Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide"
Neurobiology of aging 34 (12): 2805-2814, 2013.
[11] خندان و همکاران، "بررسی مکانیسم مولکولی جلوگیری از تشکیل تودههای بتا-آمیلویید توسط پنتاپپتاید به روش شبیهسازی داکینگ و دینامیک مولکولی" مهندسی مکانیک مدرس، دوره 15، شماره 1: 39-48، 1393.
[12] H. Alonso, A. A. Bliznyuk, J. E. Gready, "Combining docking and molecular dynamic simulations in drug design" Medicinal Research Reviews 26 (5): 531-568, 2006.
[13] T.
Lührs, C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, H. Döbeli, D. Schubert, R. Riek, "3D structure of Alzheimer's amyloid-β (1–42) fibrils"
Proceedings of the National Academy of Sciences of the United States of America 102 (48): 17342-17347, 2005.
[14] S. Kalyaanamoorthy, Y. P. P. Chen, "Modelling and enhanced molecular dynamics to steer structure-based drug discovery" Progress in Biophysics and Molecular Biology, 2013.
[15] I. A. Vakser, C. Aflalo, "Hydrophobic docking: a proposed enhancement to molecular recognition techniques" Proteins 20 (4): 320-9, 1994.
[16] D. Kozakov, et al. "An FFT-based protein docking program with pairwise potentials" Proteins: Structure, Function, and Bioinformatics 65 (2): 392-406, 2006.
[17] D. Kozakov, D. Beglov, T. Bohnuud, S. E. Mottarella, B. Xia, D. R. Hall, S. Vajda, "How good is automated protein docking?" Protein: Structure, Function and Bioinformatics 81 (12): 2159-2166, 2013.
[18] S. R. Comeau, D. W.
Gatchell, S.
Vajda,
C. J. Camacho, "ClusPro: a fully automated algorithm for protein–protein docking"
Nucleic Acids Research 32 (suppl 2): 96-99, 2004.
[19] J. C. Phillips, et al. "Scalable molecular dynamics with NAMD" Journal of Computational Chemistry 26 (16): 1781-1802, 2005.
[20] Computational Biochemistry and Biophysics. Bahman 21 CRC Press, 1379.
[21] J. L. Abascal, R. G. Fernández, C. Vega, "Carignano, The melting temperature of the six site potential model of water" 2006.
[22] B. W. Matthews, "Hydrophobic Interactions in Proteins, in eLS" John Wiley & Sons, Ltd, 2001.
[23] N. J. Bruce, D.
Chen, S. G.
Dastidar, G. E.
Marks, C. H.
Schein, R. A.
Bryce, "Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides"
Peptides 31 (11): 2100-2108, 2010.